腹部超声与阴道超声诊断子宫腺肌病的临床分析

Clinical Analysis of Abdominal Ultrasound and Transvaginal Ultrasonography in Diagnosis of Adenomyosis

目的探析腹部超声与阴道超声诊断子宫腺肌病的临床价值。方法方便选取该院2011年1月—2016年12月期间收治的66例子宫腺肌病患者,均给予腹部超声与阴道超声诊断,比较两种检查方式的诊断符合率。结果 66例患者均经过病理得到确诊为子宫腺肌病,其中合并子宫肌瘤31例,合并巧克力囊肿15例,合并盆腔子宫内膜异位症20例。经腹部超声诊断子宫腺肌病有44例患者,4例患者被漏诊,18例患者被误诊为子宫肌瘤,其诊断符合率为66.67%;经阴式超声诊断子宫腺肌症有58例患者,1例患者被漏诊,7例患者被误诊为子宫肌瘤,其诊断符合率为87.88%,两种检查方式子宫腺肌症诊断符合率比较差异有统计学意义(P<0.05)。结论对于子宫腺肌症以阴式超声检查,其准确率更高,漏诊误诊率低,优于腹部超声检查结果,可作为首选的检查方案,值得临床推广。

Objective To study the clinical value of abdominal ultrasound and transvaginal ultrasonography in diagnosis of adenomyosis. Methods Convenient selection 66 cases of patients with adenomyosis admitted and treated in our hospital from January 2011 to December 2016 were selected and were diagnosed by the abdominal ultrasound and transvaginal ultrasonography, and the diagnosis coincidence rate was compared between the two methods. Results The 66 cases were diagnosed with adenomyosis after the pathology diagnosis, including 31 cases with hysteromyoma, 15 cases with chocolate cyst and 20 cases with endometriosis of pelvis, and the abdominal ultrasound diagnosis showed that there were 44 cases with adenomyosis, 4 cases were missed diagnosis and 18 cases were with hysteromyoma by the missed diagnosis, and the diagnosis coincidence rate was 66.67%, and the transvaginal ultrasonography diagnosis showed that there were 58 cases with adenomyosis of uterus, 1 case were missed diagnosis and 7 cases were with hysteromyoma by missed diagnosis, and the diagnosis coincidence rate was 87.88%, and the difference in the coincidence rate of adenomyosis of uterus between the two examination methods was statistically significant（P〈0.05）. Conclusion The accurate rate of transvaginal ultrasonography for adenomyosis of uterus is higher, but the missed diagnosis and misdiagnosis rates are lower, and the examination results of it are better than those of abdominal ultrasound, which can be used as the preferred examination plan, and it is worth clinical promotion.